Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Kidney International Reports|November 24, 2025
Antiphospholipid Syndrome and the KidneyMaxime Taghavi, Lucas Jacobs, Dario Roccatello, et al.
Antibodies (Basel, Switzerland)|March 27, 2024
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaLucas Jacobs, Nader Wauters, Yahya Lablad, et al.
Case Reports in Nephrology and Dialysis|January 27, 2022
Hemolysis in a Patient during HemodialysisMaxime Taghavi, Lucas Jacobs, Saleh Kaysi, et al.
BMC Nephrology|April 27, 2023
Jejunal perforation secondary to blind insertion of peritoneal dialysis catheter: a case report and review of literatureLucas Jacobs, Mohammed Salaouatchi, Maxime Taghavi, et al.
Case Reports in Nephrology and Dialysis|September 26, 2022
Severe Bullous Pemphigoid Onset after Jugular Catheter Placement in a Patient on HemodialysisLucas Jacobs, Francesco Feoli, Pascal Bruderer, et al.
Antibodies (Basel, Switzerland)|January 22, 2024
Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the LiteratureMaxime Taghavi, Abla Jabrane, Lucas Jacobs, et al.
Neurology International|October 25, 2024
Froin's Syndrome: A Comprehensive Review of the Literature and the Addition of Two New CasesLucas Jacobs, Bertil Delsaut, Marta Lamartine S Monteiro, et al.
Frontiers in Pharmacology|February 18, 2026
<i>In vitro</i> exploration of drug-induced thrombotic microangiopathies: clues of diverse endothelial activation pathways respective to interferon-β1a, ciclosporin A, and gemcitabine exposureEdouard Cubilier, Maxime Taghavi, Eric De Prez, et al.
Frontiers in Medicine|January 20, 2025
Antiphospholipid antibodies positivity as a potential risk factor for restenosis following arteriovenous fistula stenting in hemodialysis patients: a pilot studyMaxime Taghavi, Adrien Lengelé, Marc Laureys, et al.
Kidney Medicine|June 3, 2026
First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose TocilizumabLucas Jacobs, Valérie Badot, Carole Nagant, et al.
Pageof 2